The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mental Disorders Drugs Market Research Report 2025
Synopsis
The global Mental Disorders Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mental Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorders Drugs.
Report Scope
The Mental Disorders Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mental Disorders Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Disorders Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Abbott Laboratories
Segment by Type
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others
Segment by Application
Children
Adolescents
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mental Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Mental Disorders Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mental Disorders Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mental Disorders Drugs.
Report Scope
The Mental Disorders Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mental Disorders Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mental Disorders Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Pfizer
Eli Lilly
GlaxoSmithKline
AstraZeneca
Bristol-Myers Squibb
Abbott Laboratories
Segment by Type
Drugs for Schizophrenia
Antidepressants
Antipsychotics
Anxiolytics
Drugs for the Treatment of Substance and Alcohol Addiction
Drugs for Childhood and Adolescent Mental Illness
Drugs to Treat Cognitive Disorders
Sleep Disorders
Others
Segment by Application
Children
Adolescents
Adults
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mental Disorders Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mental Disorders Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mental Disorders Drugs Market Overview
1.1 Product Overview and Scope of Mental Disorders Drugs
1.2 Mental Disorders Drugs Segment by Type
1.2.1 Global Mental Disorders Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Drugs for Schizophrenia
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics
1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.7 Drugs for Childhood and Adolescent Mental Illness
1.2.8 Drugs to Treat Cognitive Disorders
1.2.9 Sleep Disorders
1.2.10 Others
1.3 Mental Disorders Drugs Segment by Application
1.3.1 Global Mental Disorders Drugs Market Value by Application: (2024-2030)
1.3.2 Children
1.3.3 Adolescents
1.3.4 Adults
1.4 Global Mental Disorders Drugs Market Size Estimates and Forecasts
1.4.1 Global Mental Disorders Drugs Revenue 2019-2030
1.4.2 Global Mental Disorders Drugs Sales 2019-2030
1.4.3 Global Mental Disorders Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mental Disorders Drugs Market Competition by Manufacturers
2.1 Global Mental Disorders Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mental Disorders Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mental Disorders Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Mental Disorders Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mental Disorders Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mental Disorders Drugs, Product Type & Application
2.7 Mental Disorders Drugs Market Competitive Situation and Trends
2.7.1 Mental Disorders Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mental Disorders Drugs Players Market Share by Revenue
2.7.3 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mental Disorders Drugs Retrospective Market Scenario by Region
3.1 Global Mental Disorders Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mental Disorders Drugs Global Mental Disorders Drugs Sales by Region: 2019-2030
3.2.1 Global Mental Disorders Drugs Sales by Region: 2019-2024
3.2.2 Global Mental Disorders Drugs Sales by Region: 2025-2030
3.3 Global Mental Disorders Drugs Global Mental Disorders Drugs Revenue by Region: 2019-2030
3.3.1 Global Mental Disorders Drugs Revenue by Region: 2019-2024
3.3.2 Global Mental Disorders Drugs Revenue by Region: 2025-2030
3.4 North America Mental Disorders Drugs Market Facts & Figures by Country
3.4.1 North America Mental Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mental Disorders Drugs Sales by Country (2019-2030)
3.4.3 North America Mental Disorders Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mental Disorders Drugs Market Facts & Figures by Country
3.5.1 Europe Mental Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mental Disorders Drugs Sales by Country (2019-2030)
3.5.3 Europe Mental Disorders Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mental Disorders Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Mental Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mental Disorders Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Mental Disorders Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mental Disorders Drugs Market Facts & Figures by Country
3.7.1 Latin America Mental Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mental Disorders Drugs Sales by Country (2019-2030)
3.7.3 Latin America Mental Disorders Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mental Disorders Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Mental Disorders Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mental Disorders Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mental Disorders Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Mental Disorders Drugs Sales by Type (2019-2030)
4.1.1 Global Mental Disorders Drugs Sales by Type (2019-2024)
4.1.2 Global Mental Disorders Drugs Sales by Type (2025-2030)
4.1.3 Global Mental Disorders Drugs Sales Market Share by Type (2019-2030)
4.2 Global Mental Disorders Drugs Revenue by Type (2019-2030)
4.2.1 Global Mental Disorders Drugs Revenue by Type (2019-2024)
4.2.2 Global Mental Disorders Drugs Revenue by Type (2025-2030)
4.2.3 Global Mental Disorders Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Mental Disorders Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mental Disorders Drugs Sales by Application (2019-2030)
5.1.1 Global Mental Disorders Drugs Sales by Application (2019-2024)
5.1.2 Global Mental Disorders Drugs Sales by Application (2025-2030)
5.1.3 Global Mental Disorders Drugs Sales Market Share by Application (2019-2030)
5.2 Global Mental Disorders Drugs Revenue by Application (2019-2030)
5.2.1 Global Mental Disorders Drugs Revenue by Application (2019-2024)
5.2.2 Global Mental Disorders Drugs Revenue by Application (2025-2030)
5.2.3 Global Mental Disorders Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Mental Disorders Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Corporation Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Johnson & Johnson Mental Disorders Drugs Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Mental Disorders Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Eli Lilly
6.3.1 Eli Lilly Corporation Information
6.3.2 Eli Lilly Description and Business Overview
6.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Eli Lilly Mental Disorders Drugs Product Portfolio
6.3.5 Eli Lilly Recent Developments/Updates
6.4 GlaxoSmithKline
6.4.1 GlaxoSmithKline Corporation Information
6.4.2 GlaxoSmithKline Description and Business Overview
6.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GlaxoSmithKline Mental Disorders Drugs Product Portfolio
6.4.5 GlaxoSmithKline Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Mental Disorders Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bristol-Myers Squibb Mental Disorders Drugs Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Abbott Laboratories Mental Disorders Drugs Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mental Disorders Drugs Industry Chain Analysis
7.2 Mental Disorders Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mental Disorders Drugs Production Mode & Process
7.4 Mental Disorders Drugs Sales and Marketing
7.4.1 Mental Disorders Drugs Sales Channels
7.4.2 Mental Disorders Drugs Distributors
7.5 Mental Disorders Drugs Customers
8 Mental Disorders Drugs Market Dynamics
8.1 Mental Disorders Drugs Industry Trends
8.2 Mental Disorders Drugs Market Drivers
8.3 Mental Disorders Drugs Market Challenges
8.4 Mental Disorders Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mental Disorders Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mental Disorders Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mental Disorders Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mental Disorders Drugs Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Mental Disorders Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mental Disorders Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mental Disorders Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mental Disorders Drugs Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mental Disorders Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mental Disorders Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mental Disorders Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Mental Disorders Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mental Disorders Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mental Disorders Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mental Disorders Drugs Sales by Region (2019-2024) & (K Units)
Table 18. Global Mental Disorders Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Mental Disorders Drugs Sales by Region (2025-2030) & (K Units)
Table 20. Global Mental Disorders Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Mental Disorders Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mental Disorders Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Mental Disorders Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mental Disorders Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Mental Disorders Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mental Disorders Drugs Sales by Country (2019-2024) & (K Units)
Table 27. North America Mental Disorders Drugs Sales by Country (2025-2030) & (K Units)
Table 28. North America Mental Disorders Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mental Disorders Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mental Disorders Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mental Disorders Drugs Sales by Country (2019-2024) & (K Units)
Table 32. Europe Mental Disorders Drugs Sales by Country (2025-2030) & (K Units)
Table 33. Europe Mental Disorders Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mental Disorders Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mental Disorders Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mental Disorders Drugs Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Mental Disorders Drugs Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Mental Disorders Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mental Disorders Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mental Disorders Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mental Disorders Drugs Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Mental Disorders Drugs Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Mental Disorders Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mental Disorders Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mental Disorders Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mental Disorders Drugs Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Mental Disorders Drugs Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Mental Disorders Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mental Disorders Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mental Disorders Drugs Sales (K Units) by Type (2019-2024)
Table 51. Global Mental Disorders Drugs Sales (K Units) by Type (2025-2030)
Table 52. Global Mental Disorders Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Mental Disorders Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Mental Disorders Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mental Disorders Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mental Disorders Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Mental Disorders Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Mental Disorders Drugs Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Mental Disorders Drugs Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Mental Disorders Drugs Sales (K Units) by Application (2019-2024)
Table 61. Global Mental Disorders Drugs Sales (K Units) by Application (2025-2030)
Table 62. Global Mental Disorders Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Mental Disorders Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Mental Disorders Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mental Disorders Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mental Disorders Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Mental Disorders Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Mental Disorders Drugs Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Mental Disorders Drugs Price (USD/Pcs) by Application (2025-2030)
Table 70. Johnson & Johnson Corporation Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Johnson & Johnson Mental Disorders Drugs Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Pfizer Mental Disorders Drugs Product
Table 79. Pfizer Recent Developments/Updates
Table 80. Eli Lilly Corporation Information
Table 81. Eli Lilly Description and Business Overview
Table 82. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Eli Lilly Mental Disorders Drugs Product
Table 84. Eli Lilly Recent Developments/Updates
Table 85. GlaxoSmithKline Corporation Information
Table 86. GlaxoSmithKline Description and Business Overview
Table 87. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. GlaxoSmithKline Mental Disorders Drugs Product
Table 89. GlaxoSmithKline Recent Developments/Updates
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. AstraZeneca Mental Disorders Drugs Product
Table 94. AstraZeneca Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Bristol-Myers Squibb Mental Disorders Drugs Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Abbott Laboratories Corporation Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Abbott Laboratories Mental Disorders Drugs Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Mental Disorders Drugs Distributors List
Table 108. Mental Disorders Drugs Customers List
Table 109. Mental Disorders Drugs Market Trends
Table 110. Mental Disorders Drugs Market Drivers
Table 111. Mental Disorders Drugs Market Challenges
Table 112. Mental Disorders Drugs Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mental Disorders Drugs
Figure 2. Global Mental Disorders Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mental Disorders Drugs Market Share by Type in 2023 & 2030
Figure 4. Drugs for Schizophrenia Product Picture
Figure 5. Antidepressants Product Picture
Figure 6. Antipsychotics Product Picture
Figure 7. Anxiolytics Product Picture
Figure 8. Drugs for the Treatment of Substance and Alcohol Addiction Product Picture
Figure 9. Drugs for Childhood and Adolescent Mental Illness Product Picture
Figure 10. Drugs to Treat Cognitive Disorders Product Picture
Figure 11. Sleep Disorders Product Picture
Figure 12. Others Product Picture
Figure 13. Global Mental Disorders Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 14. Global Mental Disorders Drugs Market Share by Application in 2023 & 2030
Figure 15. Children
Figure 16. Adolescents
Figure 17. Adults
Figure 18. Global Mental Disorders Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Mental Disorders Drugs Market Size (2019-2030) & (US$ Million)
Figure 20. Global Mental Disorders Drugs Sales (2019-2030) & (K Units)
Figure 21. Global Mental Disorders Drugs Average Price (USD/Pcs) & (2019-2030)
Figure 22. Mental Disorders Drugs Report Years Considered
Figure 23. Mental Disorders Drugs Sales Share by Manufacturers in 2023
Figure 24. Global Mental Disorders Drugs Revenue Share by Manufacturers in 2023
Figure 25. The Global 5 and 10 Largest Mental Disorders Drugs Players: Market Share by Revenue in 2023
Figure 26. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 27. Global Mental Disorders Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 28. North America Mental Disorders Drugs Sales Market Share by Country (2019-2030)
Figure 29. North America Mental Disorders Drugs Revenue Market Share by Country (2019-2030)
Figure 30. U.S. Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Canada Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Europe Mental Disorders Drugs Sales Market Share by Country (2019-2030)
Figure 33. Europe Mental Disorders Drugs Revenue Market Share by Country (2019-2030)
Figure 34. Germany Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. France Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. U.K. Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Italy Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Russia Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Asia Pacific Mental Disorders Drugs Sales Market Share by Region (2019-2030)
Figure 40. Asia Pacific Mental Disorders Drugs Revenue Market Share by Region (2019-2030)
Figure 41. China Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Japan Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. South Korea Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. India Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Australia Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Taiwan Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Indonesia Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Thailand Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Malaysia Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Philippines Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Latin America Mental Disorders Drugs Sales Market Share by Country (2019-2030)
Figure 52. Latin America Mental Disorders Drugs Revenue Market Share by Country (2019-2030)
Figure 53. Mexico Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Brazil Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Argentina Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Middle East & Africa Mental Disorders Drugs Sales Market Share by Country (2019-2030)
Figure 57. Middle East & Africa Mental Disorders Drugs Revenue Market Share by Country (2019-2030)
Figure 58. Turkey Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Saudi Arabia Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 60. U.A.E Mental Disorders Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 61. Global Sales Market Share of Mental Disorders Drugs by Type (2019-2030)
Figure 62. Global Revenue Market Share of Mental Disorders Drugs by Type (2019-2030)
Figure 63. Global Mental Disorders Drugs Price (USD/Pcs) by Type (2019-2030)
Figure 64. Global Sales Market Share of Mental Disorders Drugs by Application (2019-2030)
Figure 65. Global Revenue Market Share of Mental Disorders Drugs by Application (2019-2030)
Figure 66. Global Mental Disorders Drugs Price (USD/Pcs) by Application (2019-2030)
Figure 67. Mental Disorders Drugs Value Chain
Figure 68. Mental Disorders Drugs Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
